En 2020 :
- The New England Journal of Medicine : Etude PROfound
- The New England Journal of Medicine : Etude KEYNOTE-177
- The New England Journal of Medicine : Etude ARAMIS
- The New England Journal of Medicine : Etude PROSPER
- The Lancet : Etude PROPHYLOCHIP - PRODIGE 15
- Lancet Oncology : Etude Getug 17
- Lancet Oncology : Etude DEBIO 1143
- Lancet Oncology : Etude STARTRK-2
- Journal of Clinical Oncology : Etude KEYNOTE-181
- Journal of Clinical Oncology : Etude HALO 109-301
- JAMA Oncology : Etude STIC CTC Metabreast
- Advanced Science : Etude KPLEX1, KPLEX2, IDEASEIN et BCB Colon
- Annals of Oncology : Etude SANDPIPER
- Annals of Oncology : Etude Acsé Vemurafenib
- Lancet Gastroenterology & Hepatology : Etude GRECCAR 2
- European Respiratory Journal : Etude IFCT-1001 CHIVA
- Clinical Cancer Research : Etude CHIVA
- Journal of ImmunoTherapy of Cancer : Etude NIPICOL
- Angiogenesis : Etude COMET
- Clinical Chemistry : Etude ALCINA
- European Journal of Cancer : Etude REACH
- European Journal of Cancer : Etude LSMA
- European Journal of Cancer : Etude GRASPANC 2013-03
- Therapeutic Advances in Medical Oncology : Etudes Epitopes-HPV01 et HPV02
- American Journal of Clinical Nutrition : Etude IMPATOX
- International Journal of Cancer : Etude SARCOME 9
- Radiotherapy and Oncology : Etude GORTEC 2004-01
- Frontiers in Oncology : Etude REQUITE
- Frontiers in Oncology : Etude REQUITE
- Gynecologic Oncology : Etude TMRG
- Nutrients : Etude APAD 2
- Annals of Surgical Oncology : Etude NETSARC
- Annals of Surgical Oncology : Etude NETSARC 2
- Scientific Reports : Etude StoRM
- Breast Cancer Research and Treatment : Etude PACS04
- Clinical Colorectal Cancer : Etude NEXIRI-2 PRODIGE 27
- Journal of Pharmaceutical and Biomedical Analysis : Etude ALCINA 2
- BMC Cancer : Etude HYPER-LIV
- BMC Cancer : Etude SCARCE
- International Journal of Gynecology and Obstretics : Etude OVHIPEC-2
- Breast Cancer : Etude TARGIT-E
- Bull Cancer : Etude NEONIPIGA
- Cancer Radiothérapie : Etude Intra-Obs
- Recherche en Soins Infirmiers : Etude ONAC
En 2019 :
- The New England Journal of Medicine : Etude DS8201-A-U201
- The New England Journal of Medicine : Etude CARD
- The New England Journal of Medicine : Etude PAOLA-1
- The New England Journal of Medicine : Etude PRIMA
- The New England Journal of Medicine : Etude BEACON
- The New England Journal of Medicine : Etude MONALEESA 7
- The New England Journal of Medicine : Etude ARAMIS
- The Lancet : Etude PHARE
- Lancet Oncology : Etude Act In Sarc
- Journal of Clinical Oncology : Etude Nivoren
- Annals of Oncology : Etude VIVROVAIRE
- Annals of Oncology : Etude CANTO
- PLoS Medicine : Etude CANTO
- Clinical Chemistry : Etude CIRCUTEC
- British Journal of Surgery : Etude GRECCAR-4
- European Journal of Cancer : Etude PACS04
- European Journal of Cancer : Etude E-DIS
- Clincal Nutrition : Etude PETANC
- Clinical Pharmacology & Therapeutics : Etude PHACS
- International Journal of Radiation Oncology Biology Physics : Etude PRAVACUR
- British Journal of Cancer : Etude PRODIGE 10
- Breast Cancer Research : Etude Circe-TDM1
- Radiotherapy and Oncology : Etude FFCD0904_Phase I
- Radiotherapy and Oncology : Etude REQUITE
- Gynecologic Oncology : Etude MYCA
- Gynecologic Oncology : Etude NOVA
- Cells : Etude PRODIGE 14
- Oral Oncology : Etude LUX-Head and Neck 1
- Clinical Colorectal Cancer : Etude INOVA
- Digestive and Liver Disease : Etude ERBINOX et METHEP
- Scientific Reports : Etude KPLEX-2
- BMC Cancer : Etude APAD 1
- Radiation Oncology : Etude COHORT2004 et PHRC2005
- Clinical and Translational Radiation Onoclogy : Etude REQUITE
- Gastrointestinal Cancer Research : Etude CONSIGN
- Pleura and Peritoneum : Etude MESOTIP